BACK TO THE WIRE
AI MODELS DEVELOPINGI · Intelligence Concentrating

Claude-designed proteins hit 14/15 disease targets in lab tests

Aug 23, 2026SOURCE: forbes.com
SO WHAT

In the thousand-day window, protein-design accuracy signals that choice will concentrate around compute-backed models—rewarding those with intelligence capital over biological intuition.

A reported benchmark suggests AI-assisted protein design produced functional candidates for 14 of 15 targets. The inversion is shifting: intelligence assets are becoming the bottleneck, not the wet-lab labor.

This is Negative Resistance’s reframed reading of a reported signal. The headline and analysis above are our interpretation through the thousand-day-window lens. The original reporting lives at the source linked above.